Drug Trial Radar · NCT07018713
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
808
Actual
Start
Aug 21, 2025
Primary completion
Mar 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Merz Therapeutics GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jun 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine days with Xeomin injections compared to Placebo injections. Trial details include: * Trial duration: 52 to 55 weeks; * Screening period: 4 to 5 weeks; * Treatment duration: 4 treatments, each about 12 weeks apart; and * Visit frequency: about every 4 weeks, 14 visits in total. The first and last visit and the 4 treatment visits are on-site, the other 8 visits are remote by phone / video call.
Conditions
- Chronic Migraine
Interventions
XeominDrug
Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl)
PlaceboDrug
Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in monthly migraine days from baseline (28 days before baseline visit) to Month 6 (weeks 21 to 24 after first injection) - Dose ATime frame: Baseline to month 6
Locations
111 sites in 13 countries. Site status is shown where the registry gives one.
TrialSphere Corp, Merz Investigational Site #0010513
Chandler, Arizona
Arizona Neuroscience Research, Merz Investigational Site #0010521
Phoenix, Arizona
Baptist Health Medical Center, Merz Investigational Site #0010520
Little Rock, Arkansas
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488
Lancaster, California
Clinical Research Institute, Merz Investigational Site #0010487
Los Angeles, California
BNL Health, Merz Investigational Site #0010501
Los Angeles, California
Clinical Trials Management Services, Merz Investigational Site #0010526
Thousand Oaks, California
Hasbani Neurology, Merz Investigational Site #0010509
New Haven, Connecticut
Yale Center for Clinical Investigations, Merz Investigational Site #0010527
New Haven, Connecticut
New England Institute Neurology and Headache, Merz Investigational Site #0010441
Stamford, Connecticut
Northwest Florida Clinical Research Group, Merz Investigational Site #0010286
Gulf Breeze, Florida
Nexus Clinical Research Center, Merz Investigational Site #0010514
Homestead, Florida
Jacksonville Center for Clinical Research, Merz Investigational Site #0010515
Jacksonville, Florida
Clinical Research of Central Florida, Merz Investigational Site #0010532
Lakeland, Florida
University of Miami Miller School of Medicine, Merz Investigational Site #0010493
Miami, Florida
American Research Institute, Merz Investigational Site #0010492
Miami, Florida
Premiere Research Institute at Palm Beach Neurology, Merz Investigational Site #0010499
West Palm Beach, Florida
Accel Research - NeuroStudies, Merz Investigational Site #0010523
Decatur, Georgia
Hawaii Pacific Neuroscience, Merz Investigational Site #0010510
Honolulu, Hawaii
Kansas Institute of Research,, Merz Investigational Site #0010495
Overland Park, Kansas
Crescent City Headache and Neurology Center, Merz Investigational Site #0010517
Chalmette, Louisiana
DelRicht Clinical Research, Merz Investigational Site #0010518
New Orleans, Louisiana
Sinai Hospital of Baltimore, Merz Investigational Site #0010505
Baltimore, Maryland
MedVadis Research, Merz Investigational Site #0010524
Waltham, Massachusetts
Mass Institute of Clinical Research, Merz Investigational Site #0010506
Westborough, Massachusetts
Vida Clinical Studies, Merz Investigational Site #0010498
Dearborn Heights, Michigan
Quest Research Institute, Merz Investigational Site #0010484
Farmington Hills, Michigan
Mayo Clinic, Merz Investigational Site #0010212
Rochester, Minnesota
StudyMetrix Research, Merz Investigational Site #0010530
City of Saint Peters, Missouri
Quality Clinical Research, Merz Investigational Site #0010522
Omaha, Nebraska
Dent Neurosciences Research Center, Merz Investigational Site #0010486
Amherst, New York
Integrative Clinical Trials, Merz Investigational Site #0010496
Brooklyn, New York
New York Neurology Associates, Merz Investigational Site #0010500
New York, New York
True North Neurology, Merz Investigational Site #0010508
Port Jefferson Station, New York
Rochester Clinical Research, Merz Investigational Site #0010512
Rochester, New York
Upstate Clinical Research Associates, Merz Investigational Site #0010485
Williamsville, New York
Dayton Center for Neurological Disorders, Merz Investigational Site #0010531
Centerville, Ohio
Headache Center of Hope, Merz Investigational Site #0010528
Cincinnati, Ohio
University Hospitals Cleveland Medical Center, Merz Investigational Site #0010491
Cleveland, Ohio
Tekton Research, Merz Investigational Site #0010494
Edmond, Oklahoma
Showing 40 of 111 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.